期刊
NATURE REVIEWS CANCER
卷 12, 期 1, 页码 9-22出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3183
关键词
-
类别
资金
- NATIONAL CANCER INSTITUTE [R01CA158301] Funding Source: NIH RePORTER
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066310] Funding Source: NIH RePORTER
- Howard Hughes Medical Institute Funding Source: Medline
- NCI NIH HHS [R01 CA158301] Funding Source: Medline
- NHLBI NIH HHS [R01 HL066310] Funding Source: Medline
Hypoxia-inducible factors (HIFs) are broadly expressed in human cancers, and HIF1 alpha and HIF2 alpha were previously suspected to promote tumour progression through largely overlapping functions. However, this relatively simple model has now been challenged in light of recent data from various approaches that reveal unique and sometimes opposing activities of these HIF alpha isoforms in both normal physiology and disease. These effects are mediated in part through the regulation of unique target genes, as well as through direct and indirect interactions with important oncoproteins and tumour suppressors, including MYC and p53. As HIF inhibitors are currently undergoing clinical evaluation as cancer therapeutics, a more thorough understanding of the unique roles performed by HIF1 alpha and HIF2 alpha in human neoplasia is warranted.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据